On December 18, 2014, FDA released proposed regulations that would make prescribing information for drugs and biologics available online and prohibit distribution of paper copies as part of product packaging. FDA's stated goal is to make prescribing information widely and easily accessible to healthcare providers and consumers alike, but some consumer and provider groups are criticizing the proposed rules because they may limit access to prescribing information in communities where the Internet is not readily available. The proposed rules also go against Senate ...
Recent Updates
- Federal Regulatory Views on Cybersecurity and AI Amidst a Growing Threat Landscape
- Remote Monitoring Services Under the 2027 PFS Proposed Rule: Epstein Becker Green Submits Comments to CMS
- New DOL Guidance Reiterates Key Priorities for MHPAEA Enforcement
- The Largest Sunshine Act Penalty in History - Pharmaceutical Company Settles False Claims Act, Anti-Kickback Statute and Sunshine Act Allegations
- FTC Reverses Course on Health App Privacy